Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 10, 2023

BUY
$144.61 - $166.54 $86,766 - $99,924
600 New
600 $95,000
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $82,572 - $104,976
-600 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $79,188 - $98,250
600 New
600 $973,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Carl Stuart Investment Advisor, Inc Portfolio

Follow Carl Stuart Investment Advisor, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carl Stuart Investment Advisor, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Carl Stuart Investment Advisor, Inc with notifications on news.